STOCK TITAN

Zoetis (NYSE: ZTS) EVP Kevin Esch discloses stock, RSU, option and phantom unit holdings

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Zoetis Inc. reports insider share holdings for Executive Vice President Kevin Esch. As of the reporting date, he directly owns 267 shares of Zoetis common stock and indirectly holds 122.9323 common stock equivalents through the Zoetis Savings Plan, a 401(k) plan, as of December 31, 2025.

He also holds several equity awards: 772.2513, 306.1133, 86.8836 and 50.5137 restricted stock units that generally vest in thirds over three years from grant dates in 2023–2025, plus stock options on 1,181, 490, 545 and 391 shares at exercise prices of $156.64, $196.14, $162.07 and $201.3, typically vesting over three years and expiring ten years from grant. In addition, he holds 176.3958 phantom stock units under a supplemental savings plan that are settled in cash after separation from service.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Esch Kevin

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2026
3. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 267 D
Common Stock 122.9323(1) I 401(k)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit(2) (3) (4) Common Stock 772.2513 (5) D
Restricted Stock Unit(2) (6) (4) Common Stock 306.1133 (5) D
Restricted Stock Unit(2) (7) (4) Common Stock 86.8836 (5) D
Restricted Stock Unit(2) (8) (4) Common Stock 50.5137 (5) D
Stock Option(9) (10) (11) Common Stock 1,181 $156.64 D
Stock Option(9) (12) (11) Common Stock 490 $196.14 D
Stock Option(9) (13) (11) Common Stock 545 $162.07 D
Stock Option(14) (15) (11) Common Stock 391 $201.3 D
Phantom Stock Unit(16) (16) (16) Common Stock 176.3958 (17) D
Explanation of Responses:
1. Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of December 31, 2025.
2. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
3. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, April 30, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
4. Not applicable.
5. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
6. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
7. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
8. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 8, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events
9. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
10. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.
11. Each option expires on the tenth anniversary of the date of grant.
12. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
13. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 8, 2023.
14. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
15. Each option vests on the third anniversary of the date of grant, February 8, 2022.
16. These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
17. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 01/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Zoetis (ZTS) insider filing for Kevin Esch show?

The filing shows that Executive Vice President Kevin Esch has reported his beneficial ownership in Zoetis Inc., including common stock, restricted stock units, stock options and phantom stock units as of the stated dates.

How many Zoetis (ZTS) common shares does Kevin Esch hold directly and through the 401(k) plan?

Kevin Esch directly owns 267 shares of Zoetis common stock and indirectly holds 122.9323 common stock equivalents through the Zoetis Inc. Savings Plan (401(k)) as of December 31, 2025.

What restricted stock units (RSUs) are reported for Zoetis EVP Kevin Esch?

He reports RSU holdings of 772.2513, 306.1133, 86.8836 and 50.5137 units, each representing a contingent right to receive one share of Zoetis common stock, generally vesting one-third per year over three years from grant dates in 2023–2025 subject to continued service and certain events.

What stock options does Kevin Esch hold in Zoetis (ZTS)?

He holds stock options on 1,181, 490, 545 and 391 Zoetis common shares with exercise prices of $156.64, $196.14, $162.07 and $201.3, which generally vest over three years from grant and expire on the tenth anniversary of each grant date.

What are the phantom stock units reported for Zoetis EVP Kevin Esch?

He holds 176.3958 phantom stock units acquired under the Zoetis Supplemental Savings Plan. These are settled in cash after separation from service, with value based on Zoetis common stock plus a small cash-equivalent component typically around 5% of the unit’s total value.

Does this Zoetis insider filing indicate any recent stock purchases or sales?

The disclosure lists holdings and award balances for common stock, RSUs, options and phantom stock units as of the specified dates. It does not report any specific purchase or sale transactions.
Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Latest SEC Filings

ZTS Stock Data

56.04B
440.24M
0.09%
98.66%
1.75%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
PARSIPPANY